Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS · Real-Time Price · USD
6.92
0.00 (0.00%)
At close: Apr 2, 2026, 4:00 PM EDT
7.05
+0.13 (1.88%)
After-hours: Apr 2, 2026, 7:11 PM EDT
Alpha Tau Medical Stock Forecast
Stock Price Forecast
The 3 analysts that cover Alpha Tau Medical stock have a consensus rating of "Strong Buy" and an average price target of $8.67, which forecasts a 25.29% increase in the stock price over the next year. The lowest target is $5.00 and the highest is $12.
Price Target: $8.67 (+25.29%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Alpha Tau Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 2 | 2 | 2 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $7 → $9 | Strong Buy | Maintains | $7 → $9 | +30.06% | Mar 11, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +73.41% | Mar 10, 2026 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $5 | Buy → Hold | Downgrades | $5 | -27.75% | Mar 4, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $12 | Strong Buy | Maintains | $9 → $12 | +73.41% | Feb 24, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $8 → $7 | Strong Buy | Maintains | $8 → $7 | +1.16% | Dec 10, 2025 |
Financial Forecast
Revenue This Year
963.90K
Revenue Next Year
10.27M
from 963.90K
Increased by 965.57%
EPS This Year
-0.49
from -0.53
EPS Next Year
-0.38
from -0.49
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 2.0M | 13.2M | |||
| Avg | 963,900 | 10.3M | |||
| Low | n/a | 7.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | 1,270.4% | |||
| Avg | - | 965.6% | |||
| Low | - | 668.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.47 | -0.29 | |||
| Avg | -0.49 | -0.38 | |||
| Low | -0.49 | -0.41 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.